APC anti-human CD11c [S-HCL-3]
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0446330-V2
- Awardee
- BIOLEGEND INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $203.70
About this award
The University of Virginia awarded contract A207_PO-0446330-V2 to BioLegend Inc. on June 16, 2026, for the supply of specialized research reagents. The prime contractor will deliver one unit of APC anti-human CD11c [S-HCL-3], a fluorescently-labeled monoclonal antibody commonly used in flow cytometry applications for immunological research. The deliverable will be shipped to Nicholas Maximilian Hagspiel at the University of Virginia. The total contract value is $203.70.
This purchase order represents a single-line item transaction for biological research materials. The contract was executed in Virginia and reflects a straightforward procurement of laboratory reagents required for the University's research operations. No information regarding an extended performance period has been provided in the available contract documentation.
Line items
| Item | Total |
|---|---|
| APC anti-human CD11c [S-HCL-3] | $203.70 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0446330-V2?
Contract A207_PO-0446330-V2 was awarded to BIOLEGEND INC. by University of Virginia on June 16, 2026.
How much is contract A207_PO-0446330-V2 worth?
Its cumulative value is $203.70.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award